Erythromycin NDC 52536-103

NDC codes

FDA NDC Directory

Product NDC (as listed)52536-103Labeler and product segments. Claims need a package NDC.

Product NDC at billing width52536-0103Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
52536-103-03	52536010303	30 TABLET, FILM COATED in 1 BOTTLE (52536-103-03)Marketed from Mar 15, 2018
52536-103-13	52536010313	100 TABLET, FILM COATED in 1 BOTTLE (52536-103-13)Marketed from Mar 15, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Erythromycin
Generic name (nonproprietary): erythromycin
Active ingredients: Erythromycin — 250 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Wilshire Pharmaceuticals
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 061621
Marketing start: Mar 15, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Macrolides (Chemical structure)
Identifiers: Product ID 52536-103_f9275e3a-b44f-4839-989c-ee88d44eef46SPL ID f9275e3a-b44f-4839-989c-ee88d44eef46SPL set ID f2efbc94-64f7-4130-ab23-e5983854f730RxCUI 197650, 598006UNII 63937KV33DUPC 0352536103039, 0352536105033
Pharmacologic class: Macrolide Antimicrobial; Macrolide

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N452536010303 followed by a unit qualifier and the quantity

Package 52536-0103-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 14, 2019.

Indications (excerpt from the label)

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of Erythromycin Tablets, USP and other antibacterial drugs, Erythromycin Tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Erythromycin Tablets, USP are indicated in the treatment of infections caused by susceptible strains of the designated …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 061621

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 061621
Product	Strength	Form · route	Labeler	Product NDC
Erythromycin	Erythromycin 250 mg/1	Tablet, Film coatedOral	PD-Rx Pharmaceuticals, Inc.	55289-075
Erythromycin	Erythromycin 250 mg/1	Tablet, Film coatedOral	Arbor Pharmaceuticals, Inc.	24338-102
Erythromycin	Erythromycin 500 mg/1	Tablet, Film coatedOral	Arbor Pharmaceuticals, Inc.	24338-104
Erythromycin	Erythromycin 500 mg/1	Tablet, Film coatedOral	Wilshire Pharmaceuticals	52536-105